Semaglutide and tirzepatide are typically long-term weight loss therapy treatment options
It specifically promotes fat oxidation over carbohydrate metabolism, shifting your bodys preferred fuel source toward stored fat
Your commitment tier remains flat regardless of whether you're starting at 0.25mg or reaching higher maintenance levels, removing the financial barrier to finding your optimal dose
GLP-1 receptor agonists like semaglutide and tirzepatide have transformed the treatment of type 2 diabetes and obesity
In response to food, GLP-1 releases insulin, slows gastric emptying, inhibits glucogen, promotes satiety so you have less of an appetite, and may reduce the risk of stroke and cardiovascular disease
Bottom Line on Switching to Oral GLP-1 Oral GLP-1s like Wegovy pills simplify routines and eliminate needles but demand adherence